Rilonacept
Arcalyst (rilonacept) is a prescription medication manufactured by Kiniksa Pharmaceuticals (UK), Ltd., used to treat certain autoinflammatory conditions. It comes as a lyophilized powder in single-use vials for subcutaneous injection, with each vial containing 160 mg of rilonacept in 2 mL after reconstitution. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Arcalyst (rilonacept) is a prescription medication manufactured by Kiniksa Pharmaceuticals (UK), Ltd., used to treat certain autoinflammatory conditions. It comes as a lyophilized powder in single-use vials for subcutaneous injection, with each vial containing 160 mg of rilonacept in 2 mL after reconstitution. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Rilonacept",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Rilonacept — ANDA 125249 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125249"
}
]
|
| identifier | ANDA125249 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"fda",
"medications",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Rilonacept |
